Prenatal diagnosis of tyrosinaemia type I can be achieved in cultured amniotic cells and in chorionic villus material by testing the activity of fumarylacetoacetate hydrolase and by DNA analysis, and in amniotic fluid by succinylacetone measurement. This specific metabolite can be measured either by
β¦ LIBER β¦
Tyrosinaemia type I with normal levels of plasma tyrosine
β Scribed by I. Tavares de Almeida; P. P. Leandro; M. F. B. Silva; C. Silveira; A. Da Silva; J. Salazar de Sousa; M. Duran
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 248 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A CASE OF TYROSINAEMIA TYPE I WITH NORMA
β
A. GRENIER; S. CEDERBAUM; C. LABERGE; R. GAGNΓ; C. JAKOBS; R. M. TANGUAY
π
Article
π
1996
π
John Wiley and Sons
π
English
β 333 KB
π 1 views
Genotyping of a case of tyrosinaemia typ
β
Jacques Poudrier; Francine Lettre; Maryse St-Louis; Robert M. Tanguay
π
Article
π
1999
π
John Wiley and Sons
π
English
β 161 KB
π 1 views
Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetate hydrolase and mainly affects the liver. This disease is characterized by the presence of a high level of succinylacetone. This metabolite has been used for prenatal diagnosis from amniotic fluid samples. One case with a normal leve
Successful treatment of severe cardiomyo
β
N. AndrΓ©; B. Roquelaure; V. Jubin; C. Ovaert
π
Article
π
2005
π
Springer
π
English
β 110 KB
Plasma antioxidant capacity in two cases
β
S. Bird; N. J. Miller; J. E. Collins; C. A. Rice-Evans
π
Article
π
1995
π
Springer
π
English
β 189 KB
Absence of increased succinylacetone in
β
A. A. M. Haagen; M. Duran
π
Article
π
1987
π
Springer
π
English
β 203 KB
Tyrosinaemia type I: considerations of t
β
F. J. Spronsen; G. P. A. Smit; F. A. Wijburg; Y. Thomasse; G. Visser; H. S. A. H
π
Article
π
1995
π
Springer
π
English
β 248 KB